| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 81496 |
Zn-5,10,15,20-四(4-羧基苯基)卟啉(TCPP-Zn) |
211 |
WYQ |
2024-12-25 |
| 81497 |
Methyltetrazine-CH2NHCO-PEG6-CH2CH2COOH |
183 |
zyl |
2024-12-25 |
| 81498 |
ld-Ph-amido-PEG1-C2-NHS ester, 2101206-80-6,抗体- 药物偶联物 |
136 |
hyy |
2024-12-25 |
| 81499 |
cas:1807521-07-8,2,5-dioxopyrrolidin-1-yl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate |
120 |
h |
2024-12-25 |
| 81500 |
四价锰四苯基卟啉配合物,[XMnⅣ)TPP]2O(X=N3-或OCN-) |
149 |
WYQ |
2024-12-25 |
| 81501 |
Methyltetrazine-CH2NHCO-PEG11-CH2-C≡CH的结构式 |
129 |
zyl |
2024-12-25 |
| 81502 |
cas:126695-58-7,4-Azido-2,3,5,6-tetrafluorobenzoic Acid N-Succinimidyl ester |
139 |
h |
2024-12-25 |
| 81503 |
5,10,15,20-四-(对-十二酰氧基)苯基卟啉 (TLPPH2) |
134 |
WYQ |
2024-12-25 |
| 81504 |
cas:850180-76-6,3-azidopropanoate-N-hydroxysuccinimide ester |
144 |
h |
2024-12-25 |
| 81505 |
Methyltetrazine-CH2NHCO-PEG6-CH2-C≡CH的介绍 |
178 |
zyl |
2024-12-25 |
| 81506 |
cas:906564-59-8,5-Hexynoic Acid-NHS Ester |
217 |
h |
2024-12-25 |
| 81507 |
mPEG5-OCH2CH2COOH;甲氧基五聚乙二醇丙酸 |
184 |
wyh |
2024-12-25 |
| 81508 |
5-[4-(3,5-二-十二烷氧基苯甲酰亚胺基)苯基]-10,15,20-三苯基卟啉配体(DDTPP) |
127 |
WYQ |
2024-12-25 |
| 81509 |
cas:55750-62-4,3-(Maleimido)propionic acid N-hydroxysuccinimide ester |
183 |
h |
2024-12-25 |
| 81510 |
Meso-四(4-十四氨基甲酰苯基)卟啉(14AFPP) |
155 |
WYQ |
2024-12-25 |
| 81511 |
mPEG12-OH , 甲氧基十二聚乙二醇-羟基 |
190 |
wyh |
2024-12-25 |
| 81512 |
cas:1305053-43-3,15-(2-pyridyldithio)-4,7,10,13-tetraoxapentadecanoic acid N-hydroxysuccinimide ester |
127 |
h |
2024-12-25 |
| 81513 |
4-甲酰苯甲酸N-琥珀酰亚胺酯,60444-78-2,ADC试剂 |
205 |
hyy |
2024-12-25 |
| 81514 |
Meso-5,10,15,20-四(对氯苯基)卟啉;TP-ClPPH2 |
182 |
WYQ |
2024-12-25 |
| 81515 |
cas:317331‐86‐5,N-succinimidyl-5-(2-pyridyldithio)valerate |
158 |
h |
2024-12-25 |
| 81516 |
cas:663599-11-9,1-(4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
157 |
h |
2024-12-25 |
| 81517 |
mPEG7-NH2,甲氧基七聚乙二醇-氨基 |
208 |
wyh |
2024-12-25 |
| 81518 |
Zn-5,10,15,20-四(4-羧基苯基)卟啉(TCPP-Zn) |
201 |
WYQ |
2024-12-25 |
| 81519 |
N3-PEG4-C2-Pfp ester,1353012-00-6,抗体- 药物偶联物 |
124 |
hyy |
2024-12-25 |
| 81520 |
cas:341498-08-6,N-Succinimidyl 4-(2-pyridyldithio)pentanoate |
219 |
h |
2024-12-25 |
| 81521 |
mPEG16-NH2 ,cas:907577-50-8 ,甲氧基十六聚乙二醇-氨基 |
174 |
wyh |
2024-12-25 |
| 81522 |
cas:115088-06-7,N-Succinimidyl 4-(2-pyridyldithio)butanoate |
159 |
h |
2024-12-25 |
| 81523 |
mPEG48-Br,甲氧基四十八聚乙二醇溴代 |
132 |
wyh |
2024-12-25 |
| 81524 |
四价锰四苯基卟啉配合物,[XMnⅣ)TPP]2O(X=N3-或OCN-) |
203 |
WYQ |
2024-12-25 |
| 81525 |
mPEG11-Br,溴代十一甘醇单甲醚 |
153 |
wyh |
2024-12-25 |
| 81526 |
NHS-PEG4-azide,叠氮-PEG4-NHS酯,944251-24-5 ,ADC试剂 |
144 |
hyy |
2024-12-25 |
| 81527 |
cas:1610769-13-5,4-((S)-2-((S)-2-amino-3- methylbutanamido)-5- ureidopentanamido)benzyl 2-(pyridin- 2-yldisulfanyl)ethylcarbamate |
149 |
h |
2024-12-25 |
| 81528 |
mPEG4-OCH2COOH的结构特点,16024-66-1 |
171 |
wyh |
2024-12-25 |
| 81529 |
5,10,15,20-四-(对-十二酰氧基)苯基卟啉 (TLPPH2) |
128 |
WYQ |
2024-12-25 |
| 81530 |
四苯基钯卟啉(Pd TPP),卟啉类化合物 |
295 |
WYQ |
2024-12-25 |
| 81531 |
N3-PEG3-C2-NHS ester,1245718-89-1,抗体- 药物偶联物 |
129 |
hyy |
2024-12-25 |
| 81532 |
cas:2353409-52-4 Mal-amido-PEG8-val-gly-PAB-OH |
110 |
h |
2024-12-25 |
| 81533 |
mPEG24-NH-Mal ,甲氧基二十四聚乙二醇-NH-马来酰亚胺 |
133 |
wyh |
2024-12-25 |
| 81534 |
cas:330970-70-2 Alloc-Val-Ala-OH,抗体偶联药物 |
153 |
h |
2024-12-25 |
| 81535 |
mPEG3-SH ,甲氧基三聚乙二醇-巯基 |
147 |
wyh |
2024-12-25 |
| 81536 |
cas:150114-97-9 Fmoc-Val-Ala-OH,抗体偶联药物 |
163 |
h |
2024-12-25 |
| 81537 |
N3-PEG2-C2-NHS ester,1312309-64-0,ADC试剂 |
123 |
hyy |
2024-12-25 |
| 81538 |
Methyltetrazine-CH2NHCO-PEG12-CH2CH2NH2 |
132 |
zyl |
2024-12-25 |
| 81539 |
mPEG11-OH,甲氧基十一聚乙二醇-羟基 |
119 |
wyh |
2024-12-25 |
| 81540 |
cas:70396-18-8 Boc-Val-Ala-OH,抗体偶联药物 |
143 |
h |
2024-12-25 |